Therapy of noninfectious granulomatous skin diseases with fumaric acid esters

British Journal of Dermatology

Volumn 152, Issue 6, 2005, Pages 1290-1295

  Breuer, Kristine ^a   Gutzmer, R ^a   Volker B ^a   Kapp, A ^a   Werfel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Annular elastolytic giant cell granuloma; Fumaric acid esters; Granuloma annulare; Granulomatous cheilitis; Granulomatous skin disease; Necrobiosis lipoidica; Sarcoidosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CHLOROQUINE; CLOFAZIMINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; ESTER DERIVATIVE; FUMADERM; FUMARIC ACID DERIVATIVE; FUMARIC ACID ESTER DERIVATIVE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PSORALEN; TETRACYCLINE; THALIDOMIDE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; APPETITE DISORDER; ARTICLE; CHEILITIS; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EOSINOPHILIA; FATIGUE; FEMALE; FLATULENCE; FLUSHING; GIANT CELL GRANULOMA; GRANULOMA ANNULARE; GRANULOMATOUS SKIN DISEASE; HUMAN; IMMUNOMODULATION; LEUKOPENIA; LIVER TOXICITY; LYMPHOCYTOPENIA; MALE; NAUSEA; NECROBIOSIS LIPOIDICA; OROFACIAL GRANULOMATOSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEINURIA; PUVA; REMISSION; RETROSPECTIVE STUDY; SARCOIDOSIS; SCORING SYSTEM; SIDE EFFECT; STOMACH DISEASE; ULTRAVIOLET A RADIATION;

ADOLESCENT; ADULT; AGED; CHEILITIS; DRUG ADMINISTRATION SCHEDULE; ESTERS; FEMALE; FUMARATES; GRANULOMA ANNULARE; GRANULOMA, GIANT CELL; HUMANS; MALE; MIDDLE AGED; NECROBIOSIS LIPOIDICA; RETROSPECTIVE STUDIES; SARCOIDOSIS; SKIN DISEASES;

EID: 21644463999     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06585.x     Document Type: Article

References (28)

1. Gutzmer R, Völker B, Kapp A, Werfel T. Successful topical treatment of cutaneous sarcoidosis with tacrolimus ointment. Hautarzt 2003; 54:1193-5.
2. Setterfield J, Huilgol SC, Black MM. Generalized granuloma annulare successfully treated with PUVA. Clin Exp Dermatol 1999; 24:458-60.
3. Muchenberger S, Schoepf E, Simon JC. Phototherapy with UV-A-1 for generalized granuloma annulare (Letter). Arch Dermatol 1997; 133:1605.
4. Özkaya-Bayazit E, Büyükbabani N, Baykal C et al. Annular elastolytic giant cell granuloma: sparing of a burn scar and successful treatment with chloroquine. Br J Dermatol 1999; 140:525-30.
5. Saied N, Schwartz RA, Estes SA. Treatment of generalized granuloma annulare with dapsone. Arch Dermatol 1980; 116:1345-6.
6. Pfau A, Stolz W, Karrer S et al. Allopurinol in the treatment of cutaneous sarcoidosis. Hautarzt 1998; 49:216-8.
7. Nguyen YT, Dupuy A, Cordoliani F et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol 2004; 50:235-41.
8. Wollina U, Karte K, Geyer A et al. Clofazimine in inflammatory facial dermatosis-granuloma faciale and lipogranulomatosis subcutanea (Rothmann-Makai). Acta Derm Venereal 1996; 76:77-9.
9. Baughman RP, Lower EE. A clinical approach for the use of methotrexate for sarcoidosis. Thorax 1999; 54:742-6.
10. Darvay A, Acland KM, Russel-Jones R. Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin. Br J Dermatol 1999; 141:725-7.
11. Kouba DJ, Mimouni D, Rencic A, Nousari HC. Mycophenolate mofetil may serve as a steroid sparing agent for sarcoidosis. Br J Dermatol 2003; 148:147-8.
12. Gambichler T, Kreuter A, Freitag M et al. Clearance of necrobiosis lipoidica with fumaric acid esters. Dermatology 2003; 207:422-4.
13. Gutzmer R, Breuer K, Kiehl P et al. Successful therapy of annular elastolytic giant cell granuloma with fumaric acid esters. Dermatology 2002; 205:421-4.
14. Gutzmer R, Kapp A, Werfel T. Successful treatment of sarcoidosis with cutaneous and pulmonary involvement with fumaric acid ester. Hautarzt 2004; 55:553-7.
15. Kreuter A, Gambichler T, Altmeyer P, Brockmeyer NH. Treatment of disseminated granuloma annulare with fumaric acid esters. BMC Dermatol 2002; 2:5.
16. Nowack U, Gambichler T, Hanefeld C et al. Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC Dermatol 2002; 2:15-9.
17. Schulze-Dirks A, Petzoldt D. Disseminated granuloma annulare - successful therapy with fumaric acid esters. Hautarzt 2001; 52:228-30.
18. Mrowietz U, Christophers E, Altmeyer P. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference. Br J Dermatol 1999; 141:4-24-9.
19. Altmeyer P, Matches U, Pawlak FM. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 1994; 30:977-81.
20. Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters: results of a prospective multicenter study. Br J Dermatol 1998; 138:456-60.
21. Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003; 149:363-9.
22. Kolbach DN, Nieboer C. Fumaric acid therapy in psoriasis. Results and side-effects of 2 years of treatment. J Am Acad Dermatol 1992; 27:769-71.
23. Fayyazi A, Schweyer S, Eichmeyer B et al. Expression of IFNgamma, coexpression of TNFalpha and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res 2000; 292:384-90.
24. Petres J, Kalkhoff KW, Baron D et al. The effect of fumaric acid monoethylester on the synthesis of nucleic acids and proteins of PHA-stimulated human lymphocytes. Arch Dermatol Forsch 1975; 251:295-300.
25. Bacharach-Buhles M, Pawlak FM, Matches U et al. Fumaric acid esters (FAEs) suppress CD15- and ODP4-positive cells in psoriasis. Acta Derm Venereol Suppl 1994; 186:79-82.
26. de Jong P, Bezemer AC, Zomerdijk TP. Selective stimulation of T helper 2 cytokine responses by the antipsoriasis agent monomethyl-fumarate. Eur J Immunol 1996; 26:2067-74.
27. Ockenfels HM, Schultewolter T, Ockenfels G. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokines and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998; 139:390-5.
28. Loewe R, Holnthoner W, Gröger M et al. Dimethylfumarate inhibits TNF-induced nuclear entry of NF-κB/p65 in human endothelial cells. J Immunol 2002; 168:4781-7.